Fig. 4: WFDC21P inhibits HCC development in clinical samples.
From: Nur77-activated lncRNA WFDC21P attenuates hepatocarcinogenesis via modulating glycolysis
a WFDC21P is lower expressed in carcinoma tissues than in paired paracarcinoma tissues (n = 39). WFDC21P level was detected by RT-qPCR. b WFDC21P expression levels are decreased as HCC progress. WFDC21P expression levels in 39 paracarcinoma samples and 54 HCC samples grouped into stages I–III were detected. c WFDC21P expression levels in patients with tumor numbers of 1 or ≥2 (n = 87) and tumor sizes of ≤5 or >5 cm (n = 116) were detected by RT-qPCR. d The positive correlation between overall survival of HCC patients and WFDC21P expression levels. Survival information of 91 patients is available. e Correlation chart and heat map show the positive correlation between Nur77 and WFDC21P in clinical HCC and paracarcinoma tissues (n = 43). The expression levels of Nur77 and WFDC21P were examined by RT-qPCR. The data are represented as the means ± SEM of at least three independent experiments. *p < 0.05; **p < 0.01 and ***p < 0.001.
